Ignite Creation Date:
2024-05-06 @ 2:48 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04433156
Status:
RECRUITING
Last Update Posted:
2023-05-18
First Post:
2020-06-11
Brief Title:
VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Sponsor:
Henan Cancer Hospital
Organization:
Henan Cancer Hospital
Organization Data
Organization:
Henan Cancer Hospital
Class:
OTHER_GOV
Study ID:
HNSZLYYNHL03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Henan Cancer Hospital
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Yanyan Liu
Responsible Party Title:
Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Henan Cancer Hospital
Old Name:
None
Old Organization:
None